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 Ab stract
Many investigations prove the significant analgetic ef-
fect of vertebral augmentation. The reasons for the de-
crease in pain are found in the stabilization of fracture 
fragments as well as the toxic-thermic effect of poly-
methylmethacrylate (PMMA), used in the majority of 
cases. The techniques, primarily in use since 1984, can 
be divided in vertebro- and kyphoplasty. Vertebroplasty 
is the direct injection of PMMA into the trabecular ver-
tebral body, while kyphoplasty uses an inflatable bone 
tamp to create a cavity which is filled with highly vis-
cous cement allowing a certain degree of vertebral 
height restoration. Both techniques are used percuta-
neously. Indications for augmentation are painful os-
teoporotic vertebral fractures, metastatic osteolyses, 
and painful or destabilizing vertebral hemangiomas. In 
this article, an overview of the techniques and the his-
tory of their development is provided. The materials 
used for augmentation, the possibilities, limits, and 
complications of the techniques are discussed.
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Introduction
For the last, close to 15 years painful osteoporotic verte-
bral fractures have been treated with percutaneous verte-
bral augmentation. For countless patients this has provided 
significant reduction of pain and increased mobility imme-
diately after augmentation, with a low risk of complica-
tions. Looking back at the experience with vertebral aug-
mentation in osteoporotic fractures and metastatic 
osteolysis in spine, the results are more than encouraging 
regarding reduction of pain, increased mobility and low 
morbidity of the procedure [1–4]. The exact mechanism of 
the analgetic effect of vertebral augmentation remains un-
clear. Some investigators attribute the reduction of pain to 
the toxic and/or thermal effect of the polymethylmethac-
rylate (PMMA) cement, in terms of destruction of nerve 
fibers [5–7]. A more mechanical view attributes the effect 
to the fixation of fragments and reduction of micromotion 
and associated irritation of periosteal nerve fibers.
The first implementation of “vertebroplasty” was in 
1984 by Galibert et al. [8]. In this first case, a hemangio-
ma of the second cervical vertebra was treated – primar-
ily to achieve an embolization of the tumor through the 
exothermic and mechanical properties of PMMA ce-
ment. During the consecutive years, vertebroplasty was 
mainly used in surgical treatment of vertebral tumors. 
The encouraging analgetic effect led to the augmenta-
tion of osteoporotic vertebral fractures, the first report 
of which was in 1994 [9].
This minimally invasive technique added a surgical 
option to the traditionally conservative treatment of 
osteoporotic vertebral fractures, which includes anal-
getics, bed rest with graded mobilization, bracing, as 
well as medical treatment directed toward curbing the 
progression of osteoporosis. Through vertebroplasty, 
prolonged immobilization could often be avoided, 
which has been shown to aggravate loss of bone min-
eral density and raise the vertebral fracture risk [10]. 
The estimated, progressive [11] increase in mortality 
rate of 23% in patients > 65 years of age with vertebral 
fractures attributed to the adverse effects on pulmo-
nary function (decreased vital capacity [12]), potential 
malnutrition through reduced abdominal volume and 
the impact of chronic pain, further provided powerful 
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Figures 1a to 1f. 24-year-old female with an incomplete burst fracture 
(A3.1) without neurologic deficit sustained through a skiing accident 
(a–d). Correction of the kyphotic angle from 20° to 10° and a 95% resto-
ration of height achieved through kyphoplasty (e). At 2-month fol-
low-up (f) no loss of correction is seen with the patient experiencing 
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arguments for the widespread use of vertebral aug-
mentation techniques. This development has been par-
alleled by an extension of indications. Since objective 
evidence for recurring vertebral collapse or secondary 
osteolysis [13, 14] in augmented vertebrae has not been 
reported, vertebro- and kyphoplasty are increasingly 
being performed in younger patients (Figures 1a to 1f 
and Figures 2a to 2h). 
A number of authors advocate the use of vertebral 
augmentation in traumatic vertebral compression frac-
tures. In certain cases, the surgical anterior reconstruc-
tion can be avoided in favor of augmentation [15].
Figures 2a to 2h. Radiographs of an incom-
plete burst fracture of L1 (A3.1.1) in a 67-year-old 
female sustained through a motor vehicle ac-
cident (a). The fluoroscopic views with bipe-
dicularly placed balloons show complete frac-
ture reduction obtained on the day of the 
accident (b–e). The height restoration is main-
tained after augmentation with CT revealing 
no leakage despite the burst component of 
the fracture (e, f). The radiograph after 1 year 
and MRI follow-up after 2 years show mainte-
nance of vertebral height and disk hydration 
(g, h). At 2-year follow-up the patient is com-
pletely free of back pain.
(Case published in Unfallchirurg 2002;105:
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To date (August 2005), 507 entries on “vertebro-
plasty” and 140 on “kyphoplasty” are found in the 
Pubmed database. Encouraged by the relatively simple 
technique, percutaneous vertebral augmentation has 
been adopted in numerous specialist departments. Nev-
ertheless, this procedure requires good anatomic knowl-
edge of the spine and, despite being “minimally inva-
sive”, is a surgical intervention with rare but potentially 
serious complications.
Trends of the Technique, Mistakes, Profits
Vertebroplasty
Over the years, the vertebroplasty procedure has princi-
pally not changed. The majority of patients are suitable 
for vertebroplasty in local anesthesia. Under general an-
esthesia an attempt can be made at closed fracture reduc-
tion through prone positioning with cushions under ster-
num and pelvis. Under fluoroscopic control the vertebral 
level to be treated is identified and the corresponding 
pedicles are marked. If local anesthesia is chosen, the cu-
tis and subcutis are infiltrated with local anesthetic down 
to the surface of the bone. Through small incisions, verte-
broplasty cannulas or, optionally, 2-mm K-wires are in-
troduced via the transpedicular or transcostovertebral 
(extrapedicular) route into the vertebral body. Correct 
placement is confirmed during the passage of the pedicles 
and entry of the vertebral body through fluoroscopy in 
two planes. The use of K-wires allows these to be used as 
guide wires for large-bore vertebroplasty needles, which 
is the routine technique applied in our unit [2]. During 
the augmentation with PMMA cement, continuous fluo-
roscopic monitoring is performed, in order to immedi-
ately detect extravasations of cement. In case of extrava-
sation, augmentation should be interrupted. Filling 
volumes usually range between 2–6 ml of PMMA. After 
the PMMA cement is cured, the needles are removed 
and the skin closed. Under regular circumstances patients 
are mobilized within the first hours.
The material cost of a single-level vertebroplasty is 
approximately 200 Euros.
Kyphoplasty
The kyphoplasty technique is a more recent develop-
ment, first performed in 1998 [16]. In comparison to ver-
tebroplasty, an inflatable balloon is used to restore ver-
tebral body height and create a cavity into which PMMA 
is filled [17]. The possibility of injecting highly viscous 
cement and the impaction of trabecular bone around 
the cavity is thought to reduce cement extravasation 
during augmentation. While a unipedicular approach is 
often sufficient in vertebroplasty, kyphoplasty is often 
performed bipedicularly.
The material cost of a single-level kyphoplasty is ap-
proximately 3,000 Euros.
PMMA Cement Versus Resorbable Materials
Currently, the favored substance for filling the verte-
brae in augmentation is PMMA cement. The advantag-
es of modern PMMA formulations available for verte-
broplasty lie in the ease of handling, optimal radiopacity 
through addition of contrast medium, the immediate 
stability after curing and the relatively low cost. The in-
herent disadvantages are nonresorbability and lack of 
osteocon- or -inductivity. There are multiple known 
cardiovascular side effects [18–21] and in vitro trials 
have proven its toxicity [22, 23].
Despite initially encouraging biomechanical studies 
on resorbable cements, e.g., calciumphosphate, hy-
droxyapatite [5, 24–26], it has not been widely applied in 
vivo [27]. Current indications focus mostly on traumatic 
vertebral fractures in younger patients [27]. Problems 
associated with current resorbable cements are the un-
known properties under long-term cyclic loading in the 
traumatic fracture setting, relatively poor injectability 
that can lead to clogging of the cannulas, and difficulty 
in achieving an optimal vertebral filling. Radiopacity is 
inferior to contrast-laden PMMA. Developments will 
need to be aimed at providing resorbable, osteoinduc-
tive cements with optimized handling properties and 
enhanced elasticity closer to vertebral bone.
Adjacent-Level Fractures – Plurisegmental Injection
Secondary vertebral fractures after cement augmenta-
tion occur in 5–52% of patients [14, 28, 29] over a pe-
riod of 1–5 years. The natural history of osteoporotic 
vertebral compression fractures suggests that 11.5% of 
patients with a single vertebral fracture and 24% of pa-
tients with more than two prevalent vertebral fractures 
[30] sustain a new fracture in the following year. The 
exact cause of adjacent fractures remains unclear. Ef-
fects such as the increase in loading of the spine after 
an initial treatment remain difficult to assess. There is, 
however, biomechanical evidence that the PMMA 
augmentation of an osteoporotic vertebra increases 
the risk of fractures at adjacent levels. Berlemann et al. 
[31], in a two-vertebrae functional-unit model with one 
vertebra augmented and the other not, revealed a 
trend (p = 0.13) toward lower failure loads in the non-
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cemented vertebra with increased filling of cement of 
the other. Also, the volume of injected cement has 
been found to directly relate to the resulting stiffness 
and strength [32]. In order to investigate the efficacy of 
prophylactic vertebroplasty, Sun & Liebschner [33] 
implanted different volumes in a finite-element model. 
For successful reinforcement of osteoporotic vertebrae 
a volume comparable to that currently used in verte-
broplasty (20% of the vertebral body) was determined. 
Avoiding adjacent fractures is a current research tar-
get, one of the aspects being the development of aug-
mentation materials with a biomechanical performance 
closer to that of bone.
On the basis of osteoporosis as a systemic disease, 
multilevel vertebral collapse can occur. In these severe 
cases, some investigators [1] have employed multilevel 
augmentation. Up to six vertebrae are filled in a single 
session, the goal being to treat not only the fracture it-
self, but the overall osteoporotic weakening of the tho-
racolumbar spine (Figures 3a to 3e). 
Estimating the likelihood of further fractures remains 
difficult. Inevitably, these cases demand accurate clinical 
and especially individual evaluation. The number of ver-
tebrae augmentable per session also remains unclear. Ex-
tensive augmentation is, however, known to increase the 
amount of floating bone marrow to the pulmonary capil-
lary system in terms of fat embolism. Investigations on 
sheep [34] have proven clinically relevant fat embolism 
through the augmentation of four vertebrae. Although 
the same mechanism must occur in human vertebra, no 
Figures 3a to 3e. 39-year-old fe-
male with factor V deficiency, re-
quiring low-dose heparin therapy 
during pregnancy. After 8.5 
months immobilizing back pain 
through minimal trauma oc-
curred. The radiographs (a) re-
vealed fractures in multiple lum-
bar vertebrae. In the MRI series 6 
weeks apart (b, c) progressive ver-
tebral collapse was seen despite 
optimized osteoporotic therapy. 
The measured loss of standing 
height was 6 cm in 6 months.
Due to the rapid progression of 
multisegmental vertebral col-
lapse, multisegmental augmenta-
tion was performed in three oper-
ative sessions. In T12 bipedicular 
kyphoplasty, assisted with lordo-
plasty, distraction (d, e) was per-
formed, the remaining vertebrae 
were treated with unilateral ver-
tebroplasty. At 4-month follow-up 
the patient is ambulating freely 
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proven case of lethal fat embolism after augmentation 
has been described in the literature to our knowledge. 
Unfortunately, the amount of fatty degenerated bone 
marrow must be proportional to the grade of osteoporo-
sis. In vivo studies concerning adverse effects on pulmo-
nary function and identification of potential predictive 
factors are still lacking. As preexisting pulmonary hyper-
tension most likely constitutes a risk factor, preoperative 
echocardiography may be valuable as a screening tool. 
Testing brain natriuretic peptide (BNP) concentration, 
which is elevated through distension of the right atrium, 
may be another factor indicative of an increased risk in 
the setting of pulmonary hypertension.
Realignment
Two factors must be considered regarding realignment 
and height restoring of fractured vertebrae. Most clini-
cal papers report the restoration of vertebral height as 
the relative amount of height gained and use the adja-
cent vertebrae as reference. For instance, when the pre-
operative height of a vertebra was 60% of normal and 
90% after a procedure, the relative height restoration is 
75% and the absolute value 30%.
No report exists on how much fracture reduction is 
gained just by positioning the patient in hyperexten-
sion.
Majd et al. [35], in their cohort of 360 kyphoplasty 
procedures in 222 patients, achieved 30% height gain, 
measured anteriorly. The medial height restoration av-
eraged 50%. The average correction of the kyphotic 
angle was 7%.
Boszczyk et al. [36], in severe osteoporotic fractures, 
found an average correction of the kyphotic angle of 5% 
with kyphoplasty and no correction through vertebro-
plasty.
Lieberman et al. [17] reported on 30 patients who 
underwent 70 kyphoplasty procedures with height res-
toration of 35% (0–100%) and a correction of the ky-
photic angle of 6°.
Crandall et al. [37] found a higher grade of height 
correction (86%) in new fractures than in fractures old-
er than 4 months (79%). The correction of the kyphotic 
angle in new fractures was 7°, in chronic fractures 5°.
With the exception of one investigation [61], no 
height restoration was found with vertebroplasty. Al-
though high pressure (up to 20 bar) is developed in ver-
tebroplasty [38], it does not seem possible to achieve a 
fracture reduction without the inflatable bone tamp 
used in kyphoplasty. As mentioned above, a correction 
through positioning in hyperextention can achieve a 
certain correction on its own, with vertebroplasty this 
correction is simply fixed.
An alternative method was described by Heini & 
Orler [39], whereby the vertebra above and the vertebra 
below the fracture are initially reinforced bilaterally. 
After the cement is cured, the cannulas are used as le-
vers and a lordotic moment is applied with the facet 
joints acting as pivots. The cannulas maintain this dis-
tractive force until the fractured vertebra is cemented 
and the cement has cured. With the “lordoplasty” tech-
nique improved fracture reduction is achieved, which 
can also be combined with balloon kyphoplasty. In this 
initial report an average correction of the kyphotic an-
gle of 14° was reached in 30 patients.
Leakage of Cement
Although clinical symptoms induced through cement 
leakage are rare, most of the severe complications are 
caused by cement leakage.
Krebs et al. [38] discovered a maximum injection 
pressure of 3,215 kPa in the syringe filled with cement. 
Effects on the resulting pressure in the syringe were 
related to the speed of cement injection and viscosity 
of the cement. The size of the chosen syringe (2 ml or 5 
ml) had no influence. It remains unclear how well in-
jection pressure correlates with intravertebral pres-
sure. Baroud et al. [40] reported that intravertebral 
pressure was two orders of magnitude lower than in-
jection pressure in vitro. Using this ratio, intraverte-
bral pressure in the study of Krebs et al. [38] would be 
150 mmHg. As Bohner et al. [41] showed, viscosity 
plays a central role in affecting the injection pressure 
and, therefore, cement leakage.
Investigations on cement leakage in vertebroplasty 
report a rate of 11–76% [2, 16, 42, 43]. In investigations 
on kyphoplasty, cement leakage data ranges from 4.8% 
to 39% [36, 39, 44, 45]. Cement leakage is reported at a 
higher rate if CT scans are used. Yeom et al. [46] exam-
ined postoperative CT scans and radiographs in 49 pa-
tients undergoing 76 vertebroplasty procedures. On the 
radiographs alone 49 (66%) of 74 cement leakages were 
identified. Remarkably, leakage in the spinal canal 
through the basivertebral vein (“b-type leakages”) was 
only identified in two of 28 cases (7%).
Schmidt et al. [47] found a consistency between ra-
diographs and CT scans of only 48%. This implies that 
more than every second cement leakage remains unde-
tected in the postoperative radiographs. Studies in 
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which patients underwent postoperative CT scans, re-
veal cement leakage rates between 97% [46] and 112% 
[47] (29 leakages in 26 vertebrae). To our knowledge, 
only one investigation has been published that directly 
compares vertebroplasty and kyphoplasty cement leak-
age in similar patient groups. Boszczyk et al. [36] inves-
tigated 24 patients in whom 34 vertebrae were augment-
ed. In the vertebroplasty series 73% showed cement 
leakage in the postoperative CT scans opposed to 39% 
in the kyphoplasty series [36]. The data from the CT in-
vestigations by Yeom et al. [46], Schmidt et al. [47] and 
Boszczyk et al. [36] show that, like vertebroplasty, ky-
phoplasty also has higher rates of leakage than described 
in the literature until now.
In the majority of cases it is only a small amount of 
cement that leaks out from the vertebra. The relatively 
high rate of minor leakages does not correlate with an 
adverse outcome. If clinical symptoms occur [47], CT 
scan assessment is recommended. Accepting the high 
percentage of occult cement leakage, a preoperative ve-
nography remains without consequence. In cases of ma-
jor spinal leakage, severe neurologic deficits have, how-
ever, been reported [48–50], underlining the necessity of 
meticulous technique and high-quality image intensifiers. 
The latter will also aid in detecting venous embolism, of 
which fatalities through pulmonary embolism and even 
paradox cerebral embolism have been reported [51–54].
Other rare complications occurring in percutaneous 
augmentation are intercostal neuralgia [55] and, rarely, 
radiculopathy [56]. Three reports have been made of 
spondylitis after vertebroplasty, treated conservatively 
[57], others requiring vertebrectomy [58].
Outcome
Many retrospective and prospective investigations have 
looked into the outcome of percutaneous vertebral aug-
mentation [3, 4, 13, 35, 43, 59, 60]. Practically all studies 
document significant pain reduction, measured with the 
VAS (visual analog scale) in the majority of patients af-
ter the procedure. Winking et al. [60] prospectively fol-
lowed 28 patients with osteolytic metastases and 38 pa-
tients with osteoporotic vertebral collapse treated with 
PMMA vertebroplasty. Immediately and 6 months after 
treatment 83% of tumor patients and 92% of ostopo-
rotic patients had significant pain reduction.
Perez-Higueras et al. [13] treated 13 patients with a 
5-year follow-up with vertebroplasty. The VAS fell from 
9.07 ± 0.6 to 2.07 on the 3rd day, and averaged 2.15 at 
5 years (p < 0.001).
Due to the obvious clinical benefit, randomized 
studies are rare. To our knowledge, only Kasperk et al. 
[4] undertook a prospective controlled study with 20 pa-
tients in the conservative control group. 24 h before the 
procedure these patients determined their inclusion ei-
ther in the control group or the kyphoplasty group. 
60 patients were treated with kyphoplasty. In opposi-
tion to the control group, pain was significantly reduced 
in the kyphoplasty group (p = 0.007 vs. not significant); 
their daily activity (EVOS Score) also rose significantly 
(p = 0.001 vs. not significant).
The long-term effects of vertebral augmentation 
nevertheless remain unclear. While follow-up studies 
over 5 years for 13 patients [13] and 4 years for over 
40 patients exist [14] for vertebroplasty, long-term fol-
low-up for kyphoplasty is still lacking. There is no evi-
dence in existing studies of recurrence of symptoms at 
treated levels in the researched period of time, similarly 
no systematic signs of progressive osteolysis or mechan-
ical failure have been found. Despite the supportive 
data available and clinical experience gained in thou-
sands of patients, controlled randomized trials are in 
demand, to prove the efficacy and safety of the method 
beyond doubt and show a long-term benefit in compari-
son to conservative treatment.
Conclusion
Due to the rising number of elderly patients with spine 
disease, operative therapy of osteoporotic vertebral frac-
tures and metastatic instability through augmentation 
techniques is gaining further importance. The significant 
positive results in the investigations to date will spread its 
use and extend the indications further. Besides the risk of 
rare but severe complications, the overall effect of the 
procedures for the patients, so far, must be regarded as 
very positive. It must nevertheless be accepted that our 
indications are based more on clinical experience than on 
high-class evidence. This especially holds true for the 
treatment of vertebral trauma, where the application of 
vertebro- or kyphoplasty is a departure from the gener-
ally accepted gold standard of open reduction and inter-
nal fixation. The data available on the outcome for these 
indications is still sparse, and there is a clear responsibil-
ity on the surgeons to provide prospective investigations 
when employing these techniques and novel materials.
Future investigations will need to be directed not 
only toward the biomechanical issues surrounding ver-
tebral augmentation, but also the biological effects, one 
of the most pressing issues being the influence of aug-
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mentation (and differences between materials) on the 
nutrition of the disks via the end plates. If further sup-
portive evidence can be gathered, these techniques 
clearly have the potential of becoming a mainstay of spi-
nal surgery.
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